Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2018
Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and ActivationTom B Davidson, Alexander Lee, Melody Hsu, et al.
Cell Metabolism|May 28, 2013
EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancerIvan Babic, Erik S Anderson, Kazuhiro Tanaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240Tim R Fenton, David Nathanson, Claudio Ponte de Albuquerque, et al.
Cancer Discovery|March 28, 2013
De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patientsDavid Akhavan, Alexandra L Pourzia, Alex A Nourian, et al.
Cancer Discovery|December 7, 2011
Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistanceKazuhiro Tanaka, Ivan Babic, David Nathanson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 29, 2023
Standardising personalised diabetes care across European health settings: A person-centred outcome set agreed in a multinational Delphi studyAnn-Kristin Porth, Anouk Sjoukje Huberts, Alizé Rogge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomasBeatrice Gini, Ciro Zanca, Deliang Guo, et al.
Pageof 12